Kevin D. Brandt

2023 - Xtant Medical Holdings

In 2023, Kevin D. Brandt earned a total compensation of $947.4K as Chief Commercial Officer at Xtant Medical Holdings, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$229,827
Option Awards$144,743
Salary$415,000
Stock Awards$144,599
Other$13,200
Total$947,369

Brandt received $415K in salary, accounting for 44% of the total pay in 2023.

Brandt also received $229.8K in non-equity incentive plan, $144.7K in option awards, $144.6K in stock awards and $13.2K in other compensation.

Rankings

In 2023, Kevin D. Brandt's compensation ranked 1,272nd out of 2,978 executives tracked by ExecPay. In other words, Brandt earned more than 57.3% of executives.

ClassificationRankingPercentile
All
1,272
out of 2,978
57th
Division
Manufacturing
758
out of 1,637
54th
Major group
Chemicals And Allied Products
507
out of 906
44th
Industry group
Drugs
495
out of 869
43rd
Industry
Biological Products, Except Diagnostic Substances
141
out of 211
33rd
Source: SEC filing on June 10, 2024.

Brandt's colleagues

We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2023.

2023

Sean Browne

Xtant Medical Holdings

Chief Executive Officer

2023

Mark Schallenberger

Xtant Medical Holdings

Chief Operations Officer

News

You may also like